Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Medtronic

This article was originally published in The Gray Sheet

Executive Summary

Minneapolis-based firm begins shipments of its Model 9790 portable programmer, approved Nov. 18 by FDA via PMA supplement. Medtronic says the 9790 can be used with all Medtronic pacers and defibrillators but is specifically designed for use with the firm's Thera pacemakers and Jewel PCD defibrillators, both of which are still in clinical trials in the U.S. The 18-pound device is more portable than Medtronic's earlier generation 9760 and 9710 devices, the company says. The 9790 carries a list price of $19,000, but many of the systems will be loaned to hospitals using Medtronic pacers and defibrillators
Advertisement
Advertisement
UsernamePublicRestriction

Register

MT003162

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel